Erlotinib/gefitinib/osimertinibDevelopment of resistance in non-small cell lung cancer: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2021年 / 1850卷 / 1期
关键词：
D O I：
10.1007/s40278-021-93936-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：131 / 131
相关论文
共 50 条
  • [21] Gefitinib/osimertinibDevelopment of resistance in lung adenocarcinoma and stomatitis: case report
    Reactions Weekly, 2022, 1901 (1) : 256 - 256
  • [22] Effects of Erlotinib in EGFR Mutated Non-Small Cell Lung Cancers with Resistance to Gefitinib
    Costa, Daniel B.
    Nguyen, Kim-Son H.
    Cho, Young C.
    Sequist, Lecia V.
    Jackman, David M.
    Riely, GregoryJ.
    Yeap, Beow Y.
    Halmos, Balazs
    Kim, Joo H.
    Jaenne, Pasi A.
    Huberman, Mark S.
    Pao, William
    Tenen, Daniel G.
    Kobayashi, Susumu
    CLINICAL CANCER RESEARCH, 2008, 14 (21) : 7060 - 7067
  • [23] Erlotinib/osimertinibDevelopment of resistance in advanced lung adenocarcinoma: case report
    Reactions Weekly, 2019, 1781 (1) : 160 - 160
  • [24] Gefitinib/osimertinibDevelopment of resistance: case report
    Reactions Weekly, 2019, 1780 (1) : 171 - 171
  • [25] Gefitinib/osimertinibEmergence of drug resistance in non-small cell lung carcinoma: case report
    Reactions Weekly, 2019, 1784 (1) : 130 - 130
  • [26] Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer
    Yosuke Togashi
    Katsuhiro Masago
    Satohiro Masuda
    Tomoyuki Mizuno
    Masahide Fukudo
    Yasuaki Ikemi
    Yuichi Sakamori
    Hiroki Nagai
    Young Hak Kim
    Toshiya Katsura
    Michiaki Mishima
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 399 - 405
  • [27] The current situation:: Erlotinib (Tarceva®) and gefitinib (Iressa®) in non-small cell lung cancer
    Comis, RL
    ONCOLOGIST, 2005, 10 (07): : 467 - 470
  • [28] Erlotinib, docetaxel, and gefitinib in sequential cohorts with relapsed non-small cell lung cancer
    Popat, Sanjay
    Barbachano, Yolanda
    Ashley, Sue
    Norton, Alison
    O'Brien, Mary
    LUNG CANCER, 2008, 59 (02) : 227 - 231
  • [29] Comparison of gefitinib and erlotinib for Korean patients with advanced non-small cell lung cancer
    Lee, Jin Hwa
    Jo, You Ri
    Park, Hye Sung
    Ryu, Yon Ju
    Chun, Eun Mi
    Chang, Jung Hyun
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S692 - S692
  • [30] Erlotinib/gefitinibAcquired resistance in non-small cell lung cancer: 19 case reports
    Reactions Weekly, 2018, 1711 (1) : 117 - 117
12345